Humacyte Statistics Share Statistics Humacyte has 158.47M
shares outstanding. The number of shares has increased by 23.16%
in one year.
Shares Outstanding 158.47M Shares Change (YoY) 23.16% Shares Change (QoQ) 2.16% Owned by Institutions (%) 34.44% Shares Floating 125.29M Failed to Deliver (FTD) Shares 63 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 34.36M, so 21.63% of the outstanding
shares have been sold short.
Short Interest 34.36M Short % of Shares Out 21.63% Short % of Float 24.82% Short Ratio (days to cover) 14.92
Valuation Ratios The PE ratio is -4.02 and the forward
PE ratio is -5.11.
Humacyte's PEG ratio is
-0.23.
PE Ratio -4.02 Forward PE -5.11 PS Ratio 0 Forward PS 5.2 PB Ratio -11.36 P/FCF Ratio -6 PEG Ratio -0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Humacyte.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.4,
with a Debt / Equity ratio of -0.31.
Current Ratio 2.4 Quick Ratio 2.4 Debt / Equity -0.31 Debt / EBITDA -0.13 Debt / FCF -0.17 Interest Coverage -12.33
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-682.11K Employee Count 218 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -61.4% in the
last 52 weeks. The beta is 1.89, so Humacyte's
price volatility has been higher than the market average.
Beta 1.89 52-Week Price Change -61.4% 50-Day Moving Average 1.8 200-Day Moving Average 2.63 Relative Strength Index (RSI) 68.62 Average Volume (20 Days) 4,397,600
Income Statement
Revenue n/a Gross Profit -7.19M Operating Income -114.4M Net Income -148.7M EBITDA -132.23M EBIT -139.42M Earnings Per Share (EPS) -1.26
Full Income Statement Balance Sheet The company has 44.94M in cash and 16.54M in
debt, giving a net cash position of 28.4M.
Cash & Cash Equivalents 44.94M Total Debt 16.54M Net Cash 28.4M Retained Earnings -686.01M Total Assets 138.79M Working Capital 30.64M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -98.12M
and capital expenditures -1.57M, giving a free cash flow of -99.69M.
Operating Cash Flow -98.12M Capital Expenditures -1.57M Free Cash Flow -99.69M FCF Per Share -0.84
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
